Skip to content

The DRG-STIM Study: Spasticity and Postural Stability after Long-Term Dorsal Root Ganglion (DRG)-Stimulation: A One-Year Safety and Preliminary Efficacy Study in 10 Patients with Spinal Cord Injury (SCI)

The DRG-STIM Study: Spasticity and Postural Stability after Long-Term Dorsal Root Ganglion (DRG)-Stimulation: A One-Year Safety and Preliminary Efficacy Study in 10 Patients with Spinal Cord Injury (SCI) - DRG-STIM STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON50137
Enrollment
10
Registered
2020-08-26
Start date
2020-07-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

paraplegia Spinal Cord Injury (SCI)

Interventions

The invasive interventions in the study consist of: 1) Surgical placement of max. 8 DRG-leads (under local anesthesia) for a trial phase (2 weeks) 2) After 2 weeks of trial phase: surgical removal of

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Paraplegia caused by trauma, post-surgical neurological deficits or pathological spinal compression > than one year prior to inclusion - Grade A-D neurological deficit on the American Spinal Injury Association Impairment Scale (AIS) (see research protocol chapter 4) - Age >=18 years - Patient-reported and clinically confirmed refractory spasticity

Exclusion criteria

Exclusion criteria: - Level >=3 on the American Society of Anesthesiologists (ASA) Classification - Implantation with non-MRI compatible devices/materials - Polyneuropathy (PNP) or peripheral motor neuron disease as assessed during screening measurement - Complete absence of H-reflexes as assessed during screening measurement - Lumbar MRI shows

Design outcomes

Primary

MeasureTime frame
The main study parameter is (a change in) spasticity (frequency and/or intensity) in patients with motor complete and incomplete SCI who have been implanted with a permanent DRG stimulator for one year. At ten points over this year, clinical changes will be recorded and analyzed.

Secondary

MeasureTime frame
The secondary study parameters include (any changes in) postural stability as well as patient-reported differences in secondary health outcomes (functional independence, pain, bladder and bowel function, sexual function, and quality of life). The safety of chronic DRG stimulation will be monitored throughout the study.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)